Nasopharyngeal carcinoma
Conditions
Interventions
Sponsors
Department of Radiation Oncology, Xiamen Cancer Hospital, The First Affiliated Hospital of School of Medicine, Xiamen University. Teaching Hospital of Fujian Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Histopathologically confirmed NPC; (2) Karnofsky performance status (KPS) score = 80; (3) No evidence of distant metastasis; (4) No previous or concurrent malignancy; (5) Those who agreed and signed an informed consent.
Exclusion criteria
Exclusion criteria: (1)Patients with severe heart disease or cerebrovascular disease; (2)Patients with uncontrolled diabetes or uncontrolled high blood pressure; (3)Patients with renal failure; (4)Patients with active peptic ulcer; (5)Patients with severe lung disease or severe infection; (6)Patients with other complications that could have interfered with the efficacy of chemotherapy or radiotherapy; (7)Those who were pregnant or breast-feeding; (8)Those who refused further treatment; (9)Those who were allergic to MRI and PET contrast agents.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic accuracy;Long-term overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Long-term progression-free survival; | — |
Countries
China
Contacts
Public ContactQin Lin
Department of Radiation Oncology, Xiamen Cancer Hospital, The First Affiliated Hospital of School of Medicine, Xiamen University. Teaching Hospital of Fujian Medical University
Outcome results
None listed